Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1974 June; 67(6 Pt 2): 566–573.
PMCID: PMC1645578

The Immunology of Liver Disorders

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bacon PA, Berry H, Bown R. Cell-mediated immune reactivity in liver disease. Gut. 1972 Jun;13(6):427–429. [PMC free article] [PubMed]
  • Becker MD, Baptista A, Scheuer PJ, Sherlock S. Prognosis of chronic persistent hepatitis. Lancet. 1970 Jan 10;1(7637):53–57. [PubMed]
  • Ben-Yoseph Y, Shapira E, Doniach D. Further purification of the mitochondrial inner membrane autoantigen reacting with primary biliary cirrhosis sera. Immunology. 1974 Feb;26(2):311–321. [PubMed]
  • Bianchi FB, Penfold PL, Roitt IM. Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate. Br J Exp Pathol. 1973 Dec;54(6):652–657. [PubMed]
  • Bjorneboe M, Prytz H, Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet. 1972 Jan 8;1(7741):58–60. [PubMed]
  • Blajchman MA. Tissue antibodies in idiopathic autoimmune haemolytic anaemia. Clin Exp Immunol. 1971 May;8(5):741–748. [PubMed]
  • Brostoff J. Migration inhibition studies in human disease. Proc R Soc Med. 1970 Sep;63(9):905–906. [PMC free article] [PubMed]
  • Bundey S, Doniach D, Soothill JF. Immunological studies in patients with juvenile-onset myasthenia gravis and in their relatives. Clin Exp Immunol. 1972 Jul;11(3):321–332. [PubMed]
  • Cantor HM, Dumont AE. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature. 1967 Aug 12;215(5102):744–745. [PubMed]
  • Christoffersen P, Poulsen H, Scheuer PJ. Abnormal bile duct epithelium in chronic aggressive hepatitis and primary biliary cirrhosis. Hum Pathol. 1972 Jun;3(2):227–235. [PubMed]
  • De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. [PubMed]
  • Doniach D, Delhanty J, Lindqvist HJ, Catterall RD. Mitochondrial and other tissue autoantibodies in patients with biological false positive reactions for syphilis. Clin Exp Immunol. 1970 Jun;6(6):871–884. [PubMed]
  • Doniach D, Roitt IM, Walker JG, Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PubMed]
  • Doniach D, Walker JG. A unified concept of autoimmune hepatitis. Lancet. 1969 Apr 19;1(7599):813–815. [PubMed]
  • Doniach D, Walker JG, Roitt IM, Berg PA. "Autoallergic" hepatitis. N Engl J Med. 1970 Jan 8;282(2):86–88. [PubMed]
  • Dudley FJ, O'Shea MJ, Ajdukiewicz A, Sherlock S. Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease. Gut. 1973 May;14(5):360–364. [PMC free article] [PubMed]
  • Eyquem A, Gurow L. L'auto-immunité en hépatologie: l'exploration sérologique par déviation du complément, hémagglutination possive et précipitation. Acta Gastroenterol Belg. 1968 Jun;31(6):379–398. [PubMed]
  • Farrow LJ, Holborow EJ, Johnson GD, Lamb SG, Stewart JS, Taylor PE, Zuckerman AJ. Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J. 1970 Jun 20;2(5711):693–695. [PMC free article] [PubMed]
  • Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. [PMC free article] [PubMed]
  • Feizi T, Naccarato R, Sherlock S, Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol. 1972 Apr;10(4):609–622. [PubMed]
  • Fischer JA, Schmid M. Treatment of primary biliary cirrhosis with azothioprine. Lancet. 1967 Feb 25;1(7487):421–424. [PubMed]
  • Fulford KW, Catterall RD, Delhanty JJ, Doniach D, Kremer M. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain. 1972;95(2):373–386. [PubMed]
  • Galbraith RM, Smith M, Mackenzie RM, Tee DE, Doniach D, Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. [PubMed]
  • Grob PJ, Jemelka H. Faecal S.H. (Australia) antigen in acute hepatitis. Lancet. 1971 Jan 30;1(7692):206–208. [PubMed]
  • Hadziyannis S, Scheuer PJ, Feizi T, Naccarato R, Doniach D, Sherlock S. Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol. 1970 Mar;23(2):95–98. [PMC free article] [PubMed]
  • Holborow EJ. Smooth-muscle autoantibodies, viral infections and malignant disease. Proc R Soc Med. 1972 May;65(5):481–484. [PMC free article] [PubMed]
  • Ireton HJ, Muller HK, McGiven AR. Human antibody against rat gastric parietal cells and kidney brush border. Clin Exp Immunol. 1971 May;8(5):783–789. [PubMed]
  • Johnson GD, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet. 1965 Oct 30;2(7418):878–879. [PubMed]
  • Joske RA, Laurence BH. Familial cirrhosis with autoimmune features and raised immunoglobulin levels. Gastroenterology. 1970 Oct;59(4):546–552. [PubMed]
  • Kaplowitz N, Finlayson ND, Walmsley P, Thurnherr N, Javitt NB. Hepatobiliary diseases associated with serum antimitochondrial antibody (AMA). Am J Med. 1973 Jun;54(6):725–730. [PubMed]
  • Klatskin G, Kantor FS. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med. 1972 Oct;77(4):533–541. [PubMed]
  • Lam KC, Mistilis SP, Perrott N. Positive tissue antibody tests in patients with prolonged extrahepatic biliary obstruction. N Engl J Med. 1972 Jun 29;286(26):1400–1401. [PubMed]
  • Miller J, Smith MG, Mitchell CG, Reed WD, Eddleston AL, Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. [PubMed]
  • Mistilis SP, Skyring AP, Blackburn CR. Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival. Australas Ann Med. 1968 Aug;17(3):214–223. [PubMed]
  • Muller HK, McGiven AR, Nairn RC. Immunofluorescent staining of rat gastric parietal cells by human antibody unrelated to pernicious anaemia. J Clin Pathol. 1971 Feb;24(1):13–14. [PMC free article] [PubMed]
  • Pearson AJ, Grainger JM, Scheuer PJ, McIntyre N. Jaundice due to oxyphenisatin. Lancet. 1971 May 15;1(7707):994–996. [PubMed]
  • Popper H, Paronetto F, Schaffner F. Immune processes in the pathogenesis of liver disease. Ann N Y Acad Sci. 1965 Jun 30;124(2):781–799. [PubMed]
  • Popper H, Schaffner F. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. Prog Liver Dis. 1970;3:336–354. [PubMed]
  • Protell RL, Soloway RD, Martin WJ, Schoenfield LJ, Summerskill WH. Anti-Salmonella agglutinins in chronic active liver disease. Lancet. 1971 Aug 14;2(7720):330–332. [PubMed]
  • Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971 Oct 7;285(15):813–820. [PubMed]
  • Rizzetto M, Bianchi FB, Doniach D. Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology. 1974 Mar;26(3):589–601. [PubMed]
  • Rizzetto M, Swana G, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973 Nov;15(3):331–344. [PubMed]
  • Rodriguez M, Paronetto F, Schaffner F, Popper H. Antimitochondrial antibodies in jaundice following drug administration. JAMA. 1969 Apr 7;208(1):148–150. [PubMed]
  • Singleton JW, Merrill DA, Fitch RA, Kohler PF, Rettberg WA. Liver disease in Australia-antigen-positive blood-donors. Lancet. 1971 Oct 9;2(7728):785–787. [PubMed]
  • Smith MG, Golding PL, Eddleston AL, Mitchell CG, Kemp A, Williams R. Cell-mediated immune responses in chronic liver diseases. Br Med J. 1972 Feb 26;1(5799):527–530. [PMC free article] [PubMed]
  • Smith MG, Williams R, Doniach D, Calne RY. Effect of orthotopic liver transplantation on serum-autoantibodies. Lancet. 1971 Nov;2(7732):1006–1009. [PubMed]
  • Smith MG, Williams R, Walker G, Rizzetto M, Doniach D. Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J. 1974 Apr 13;2(5910):80–84. [PMC free article] [PubMed]
  • Strickland RG, Hooper B. The parietal cell heteroantibody in human sera: prevalence in a normal population and relationship to parietal cell autoantibody. Pathology. 1972 Oct;4(4):259–263. [PubMed]
  • Thomas HC, McSween RN, White RG. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet. 1973 Jun 9;1(7815):1288–1291. [PubMed]
  • Triger DR, Alp MH, Wright R. Bacterial and dietary antibodies in liver disease. Lancet. 1972 Jan 8;1(7741):60–63. [PubMed]
  • Triger DR, MacCallum FO, Kurtz JB, Wright R. Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet. 1972 Mar 25;1(7752):665–667. [PubMed]
  • Triger DR, Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. [PubMed]
  • Walker JG, Doniach D, Doniach I. Mitochondrial antibodies and subclinical liver disease. Q J Med. 1970 Jan;39(153):31–48. [PubMed]
  • Wartenberg J, Doniach D, Brostoff J, Roitt IM. Leucocyte migration inhibition with mitochondria in human autoimmune thyroid disorders. Clin Exp Immunol. 1973 Jun;14(2):203–212. [PubMed]
  • Whaley K, Goudie RB, Williamson J, Nuki G, Dick WC, Buchanan WW. Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet. 1970 Apr 25;1(7652):861–863. [PubMed]
  • Whittingham S, Mackay IR, Kiss ZS. An interplay of genetic and environmental factors in familial hepatitis and myasthenia gravis. Gut. 1970 Oct;11(10):811–816. [PMC free article] [PubMed]
  • Wright JM, Doniach D. The significance of cardiolipin immunofluorescence (CLF). Proc R Soc Med. 1971 Apr;64(4):419–422. [PMC free article] [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press